Clinical Trial Update: Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating prophylactic intravesical chemotherapy to prevent bladder recurrence after nephroureterectomy for primary upper tract urotheli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Upper Tract Urothelial Carcinoma

Drugs mentioned

• Intravesical chemotherapy (undisclosed agent)

Snippet

Sponsor: Peking University First Hospital | Conditions: Bladder Recurrence, Upper Tract Urothelial Carcinoma | Phase 2 | Status: UNKNOWN